453 results match your criteria: "Hospital "San Giuseppe Moscati"[Affiliation]"

Article Synopsis
  • Natalizumab outperforms fingolimod in reducing relapses in patients with relapsing-remitting multiple sclerosis (RRMS), but it's unclear if this holds true for all demographic groups.
  • The study aimed to assess the effectiveness of these treatments across different patient subgroups, considering factors like age, sex, disease duration, and disability status.
  • Results showed that natalizumab led to fewer relapses and a higher chance of improving disability in various subgroups, indicating its potential superiority, particularly in younger patients and those with less severe disease.
View Article and Find Full Text PDF
Article Synopsis
  • A 5-month-old boy was examined for a large bump on his chest that had been present since birth.
  • An ultrasound showed a soft tissue mass with specific characteristics, leading to the diagnosis of a dermoid cyst, which is rare in the midsternal area.
  • Despite similarities to other cystic masses, unique ultrasound features like an anechoic cyst with an internal echogenic formation can help distinguish dermoid cysts in subcutaneous tissues.
View Article and Find Full Text PDF

Background: Healthy individuals and patients with cancer who are carriers of germline pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that require appropriate counseling and specific expertise.

Main Body: On December 5th-7th, 2019, patient advocates and physicians with expertise in the field of reproductive medicine, fertility preservation, and oncology were invited to "San Giuseppe Moscati" Hospital in Avellino (Italy) for a workshop on reproductive management of women with germline pathogenic variants in the BRCA1/2 genes. From the discussion regarding the current evidence and future prospective in the field, eight main research questions were formulated and eight recommendations were developed regarding fertility, fertility preservation, preimplantation genetic testing, and pregnancy in healthy carriers and patients with cancer.

View Article and Find Full Text PDF

Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.

Blood

June 2022

Severe Aplastic Anemia Working Party, European Group for Bone Marrow Transplantation.

Article Synopsis
  • Complement is a crucial part of the immune system, with genetic and autoimmune factors causing excessive activation linked to diseases like paroxysmal nocturnal hemoglobinuria (PNH).
  • Eculizumab was the first approved complement inhibitor for PNH in 2007, followed by newer treatments like ravulizumab and pegcetacoplan that address unmet needs in therapy.
  • Current research is exploring various complement inhibitors for additional hematologic conditions, emphasizing the importance of a personalized treatment approach based on specific patient needs.
View Article and Find Full Text PDF

Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms.

Rhinology

October 2021

Postgraduate School of Respiratory Medicine, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy; Department of Experimental Medicine, Unit of Respiratory Medicine, University of Rome, Tor Vergata, Rome, Italy.

View Article and Find Full Text PDF

Hemothorax (HT) and pulmonary hematoma represent rare complications of anticoagulant therapy. We present a rare case of a 53-year-old man with COVID-19 pneumonia who showed, in a follow-up computed tomography (CT) scan 13 days after hospitalization, a left HT and a small hyperdense area in a subpleural location and compatible with a small subpleural hematoma. This patient was being treated with a subcutaneous administration of low-molecular-weight heparin (100UI/kg/BID).

View Article and Find Full Text PDF

How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.

Br J Haematol

January 2022

Severe Aplastic Anaemia Working Party (SAAWP) of the European Group for Bone Marrow Transplantation (EBMT), Leiden, the Netherlands.

Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by complement-mediated intravascular haemolysis, severe thrombophilia and bone marrow failure. While for patients with bone marrow failure the treatment follows that of immune-mediated aplastic anaemia, that of classic, haemolytic PNH is based on anti-complement medication. The anti-C5 monoclonal antibody eculizumab has revolutionized treatment, resulting in control of intravascular haemolysis and thromboembolic risk, with improved long-term survival.

View Article and Find Full Text PDF

Introduction: Bowel dysfunction (BD) is reported as a common and disabling symptom in multiple sclerosis (MS) patients. To date, no studies have explored the prevalence of these symptoms in a large multicenter outpatient setting. The aims of the present study are to assess: (i) the prevalence of BD in a large multicenter Italian MS population, and (ii) the correlation between clinico-demographic variables and the severity of BD.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the effectiveness of hydroxychloroquine (HCQ) in treating COVID-19 by observing 4,396 patients hospitalized in Italy from February to May 2020, revealing mixed results from previous research.
  • Two patient clusters were identified: a younger, healthier group at lower risk of death and an older, sicker group at higher risk, highlighting differing impacts of HCQ on these populations.
  • HCQ appeared to significantly reduce mortality risk in the lower risk cluster, suggesting that it may be more beneficial for patients with fewer comorbidities, potentially clarifying debates around its efficacy in COVID-19 treatment.
View Article and Find Full Text PDF

Background: One of the most problematic expression of ageing is frailty, and an approach based on its early identification is mandatory. The Sunfrail-tool (ST), a 9-item questionnaire, is a promising instrument for screening frailty.

Aims: To assess the diagnostic accuracy and the construct validity between the ST and a Comprehensive Geriatric Assessment (CGA), composed by six tests representative of the bio-psycho-social model of frailty; To verify the discriminating power of five key-questions of the ST; To investigate the role of the ST in a clinical-pathway of falls' prevention.

View Article and Find Full Text PDF

Background: In recent years, the number of clinical practice guidelines (CPGs) for lung cancer has increased, but the quality of these guidelines has not been systematically assessed so far. Our aim was to assess the reporting quality of CPGs on lung cancer published since 2018 using the International Reporting Items for Practice Guidelines in Health Care (RIGHT) instrument.

Methods: We systematically searched the major electronic literature databases, guideline databases and medical society websites from January 2018 to November 2020 to identify all CPGs for small cell and non-small cell lung cancer (NSCLC).

View Article and Find Full Text PDF

A scoping review of retracted publications in anesthesiology.

Saudi J Anaesth

April 2021

Division of Anesthesia and Pain Medicine, Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italy.

Context: Fraudulent publication is a scourge of scientific research.

Objectives: This scoping review was aimed at characterizing retracted publications for fraud or plagiarism in the field of anesthesia. Does the reputation of the journal (Quartile and Impact Factor, IF) protect the reader from the risk of having the manuscript he read withdrawn for fraud/plagiarism?

Methods/design: This scoping review was planned following the Joanna Briggs Institute recommendations.

View Article and Find Full Text PDF

Protease inhibitors have been considered as possible therapeutic agents for COVID-19 patients. To describe the association between lopinavir/ritonavir (LPV/r) or darunavir/cobicistat (DRV/c) use and in-hospital mortality in COVID-19 patients. Multicenter observational study of COVID-19 patients admitted in 33 Italian hospitals.

View Article and Find Full Text PDF

Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.

Comput Methods Programs Biomed

September 2021

I-Biostat, Data Science Institute, Hasselt University, Diepenbeek, Belgium; Department of Immunology, Biomedical Research Institute, Hasselt University, Diepenbeek 3590, Belgium; Department of Immunology, Biomedical Research Institute, Hasselt University, Diepenbeek 3590, Belgium; I-Biostat, Data Science Institute, Hasselt University, Diepenbeek, Belgium. Electronic address:

Article Synopsis
  • Research on Multiple Sclerosis (MS) is shifting towards using real-world clinical data to understand patient disability progression, as this data can provide more insights despite being less controlled than clinical trial data.
  • The study employed advanced machine learning techniques, like recurrent neural networks, using data from 6,682 MS patients to analyze their health trajectories.
  • Results indicate a significant improvement in predicting disability progression over two years, achieving an ROC-AUC of 0.85, which enhances the accuracy of MS prognosis and supports the move towards AI-assisted precision medicine.
View Article and Find Full Text PDF

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies.

Mult Scler Relat Disord

August 2021

The Danish Multiple Sclerosis Registry, Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark; The Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet Glostrup, Denmark.

Background: Natalizumab and fingolimod were the first preparations recommended for disease breakthrough in priorly treated relapsing-remitting multiple sclerosis. Of three published head-to-head studies two showed that natalizumab is the more effective to prevent relapses and EDSS worsening.

Methods: By re-analyzing original published results from MSBase, France, and Denmark using uniform methodologies, we aimed at identifying the effects of differences in methodology, in the MS-populations, and at re-evaluating the differences in effectiveness between the two drugs.

View Article and Find Full Text PDF

Background: To reduce the overall exposure to dexamethasone (DEX) in patients receiving cisplatin-based chemotherapy, we evaluated the noninferiority of DEX on day 1, with or without low-dose DEX on days 2 and 3, combined with an oral fixed-dose combination of netupitant and palonosetron (NEPA), compared with the guideline-consistent use of 4-day DEX.

Patients And Methods: In this open-label, multicenter study, chemotherapy-naïve patients undergoing high-dose cisplatin (≥70 mg/m ), were given NEPA and DEX (12 mg) on day 1 and randomized (1:1:1 ratio) to receive either (a) no further DEX (DEX1), (b) oral DEX (4 mg daily) on days 2-3 (DEX3), or (c) DEX (4 mg twice daily) on days 2-4 (DEX4). The primary efficacy endpoint was complete response (CR: no emesis and no rescue medication) during the 5-day overall phase.

View Article and Find Full Text PDF
Article Synopsis
  • - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes COVID-19, which was first identified in December 2019 and led to a pandemic declared by the WHO in March 2020, affecting many people with flu-like symptoms, particularly in high-risk groups.
  • - A systematic review of literature from various databases (up to October 2020) focused on the clinical features and treatments for COVID-19, revealing multiple approaches such as antivirals, antimalarials, and corticosteroids, but no single treatment has proven definitively effective.
  • - While ongoing research is crucial for finding effective early diagnostics and treatments, mass vaccination is currently viewed as the most promising strategy
View Article and Find Full Text PDF

Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns.

Nutrients

May 2021

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.

Adverse food reactions include immune-mediated food allergies and non-immune-mediated intolerances. However, this distinction and the involvement of different pathogenetic mechanisms are often confused. Furthermore, there is a discrepancy between the perceived vs.

View Article and Find Full Text PDF

Background: Three or four cycles of cisplatin-based chemotherapy is the standard neoadjuvant treatment prior to cystectomy in patients with muscle-invasive bladder cancer. Although NCCN guidelines recommend 4 cycles of cisplatin-gemcitabine, three cycles are also commonly administered in clinical practice. In this multicenter retrospective study, we assessed a large and homogenous cohort of patients with urothelial bladder cancer (UBC) treated with three or four cycles of neoadjuvant cisplatin-gemcitabine followed by radical cystectomy, in order to explore whether three vs.

View Article and Find Full Text PDF

BRCA1, BRCA2, TP53 and ATM gene mutations are the most studied tumour suppressor genes (TSGs) influencing the loco-regional approach to breast cancer (BC). Due to altered radio sensitivity of mutated cancer cells, mastectomy has always been advised in most patients with BC linked to TSGs mutations in order to avoid or minimize the use of adjuvant radiotherapy (ART). Whether ART is safe or not in these carriers is still debated.

View Article and Find Full Text PDF

Purpose: To assess the visual and refractive outcome of immediate intraoperative vitrectomy and intrascleral intraocular lens implantation using a "standardized" sutureless Yamane technique during cataract luxation in the vitreous chamber as a complication of phacoemulsification.

Design: A prospective, interventional, consecutive case series.

Materials And Methods: Twelve patients underwent vitrectomy and intrascleral intraocular lens fixation using a standardized Yamane technique as the primary procedure during complicated phacoemulsification.

View Article and Find Full Text PDF

Background: The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety and tolerability of galcanezumab in the prevention of high-frequency episodic migraine (HFEM) and chronic migraine (CM) in a real-life setting.

Methods: This multicenter prospective observational cohort study was conducted between November 2019 and January 2021 at 13 Italian headache centers.

View Article and Find Full Text PDF

Lessons from peculiar cases of anaphylaxis: why allergists should be prepared for the unexpected.

Eur Ann Allergy Clin Immunol

May 2022

Postgraduate School of Respiratory Medicine, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.

Anaphylaxis is the most severe systemic hypersensitivity reaction, it can be caused by a number of well identified triggers such as foods, drugs, stinging insects and facilitated by predisposing clinical conditions. However, sometimes anaphylaxis shows up with uncommon or peculiar characteristics which could delay diagnosis and therapeutic treatment. In this report we aimed to describe less accounted / difficult-to-approach shapes of anaphylaxis to facilitate clinicians to suspect these severe reactions even in uncommon conditions.

View Article and Find Full Text PDF